Heron Therapeutics(DE:AXD2)
€0.34+0.01 (+1.52%)
DE:AXD2
Heron Therapeutics earnings date
€0.34
At close:+0.01 (+1.52%)
Heron Therapeutics (AXD2) Q3 2026 Earnings Report
4 Followers
DE:AXD2 Q3 2026 EPS Results
- Actual EPS
- -EUR 0.03
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.09
DE:AXD2 Q3 2026 Revenue Results
- Actual Revenue
- EUR 31.56M
- Expected Revenue
- EUR 33.58M
- Beat/Miss
- Missed by -EUR 2.01M
- YoY Revenue Growth
- -7.75%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/09/2026
- Time
- Before Open
- Conference Call
- Monday, November 9, 2026
DE:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.03- | -0.02 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.02-0.03 | -0.09 | 70.00% (+0.06) | |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.03 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.04 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.09 | -0.03 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.04) | |
| May 06, 2025 | 2025 (Q1) | -0.010.01 | -0.02 | 150.00% (+0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.03 | -0.15 | 82.35% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
